• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 5-Chloro-2-methylbenzothiazol-6-amine (CAS No. 101253-50-3)

5-Chloro-2-methylbenzothiazol-6-amine, identified by the Chemical Abstracts Service Number (CAS No.) 101253-50-3, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the benzothiazole class, a structural motif widely recognized for its biological activity and utility in drug development. The presence of both chloro and methyl substituents on the benzothiazole core introduces unique electronic and steric properties, making it a promising scaffold for designing novel therapeutic agents.

The benzothiazole ring system is a privileged structure in medicinal chemistry, exhibiting a broad spectrum of biological activities including antimicrobial, anti-inflammatory, anticancer, and antiviral properties. The specific substitution pattern in 5-Chloro-2-methylbenzothiazol-6-amine enhances its potential as a pharmacophore, enabling interactions with biological targets such as enzymes and receptors. Recent studies have highlighted the importance of benzothiazole derivatives in the development of small-molecule inhibitors for various diseases, particularly in oncology and neurology.

In the context of modern drug discovery, 5-Chloro-2-methylbenzothiazol-6-amine has been investigated for its potential role in modulating key cellular pathways. For instance, research has demonstrated its ability to interfere with the activity of certain kinases, which are critical enzymes in cancer progression. The chloro substituent at the 5-position increases the electrophilicity of the molecule, facilitating nucleophilic attacks by biological targets, while the methyl group at the 2-position influences the overall conformation and solubility characteristics. These structural features make it an attractive candidate for further derivatization and optimization.

One of the most compelling aspects of 5-Chloro-2-methylbenzothiazol-6-amine is its versatility in chemical modification. Researchers have explored various synthetic strategies to introduce additional functional groups or alter the substitution pattern, aiming to enhance potency, selectivity, and pharmacokinetic properties. For example, coupling this compound with other heterocycles or appending bioisosteric moieties can lead to novel derivatives with improved biological profiles. Such modifications are often guided by computational modeling and high-throughput screening techniques to identify lead compounds with optimal pharmacological properties.

The pharmaceutical industry has increasingly recognized the value of heterocyclic compounds like 5-Chloro-2-methylbenzothiazol-6-amine in addressing unmet medical needs. Clinical trials and preclinical studies have begun to explore its efficacy in treating conditions such as chronic inflammation and neurodegenerative disorders. The compound’s ability to cross the blood-brain barrier and interact with central nervous system receptors makes it particularly relevant for neurological applications. Additionally, its stability under physiological conditions ensures that it can be formulated into diverse dosage forms, including oral tablets and injectable solutions.

From a synthetic chemistry perspective, 5-Chloro-2-methylbenzothiazol-6-amine exemplifies the elegance of heterocyclic chemistry in producing complex molecular architectures. The synthesis typically involves multi-step reactions starting from readily available precursors such as chlorobenzene derivatives and thioamides. Advances in catalytic methods have further streamlined these processes, reducing reaction times and improving yields. This accessibility is crucial for large-scale production and commercialization of drugs derived from this scaffold.

The environmental impact of pharmaceutical intermediates like 5-Chloro-2-methylbenzothiazol-6-amine is also a consideration in modern drug development. Efforts are underway to develop greener synthetic routes that minimize waste and hazardous byproducts. Green chemistry principles are being applied to optimize processes, ensuring that production methods align with sustainability goals while maintaining high chemical purity standards. Such initiatives reflect the broader commitment within the pharmaceutical industry to responsible manufacturing practices.

In conclusion,5-Chloro-2-methylbenzothiazol-6-amines (CAS No. 101253-50-3) represents a significant advancement in medicinal chemistry due to its structural complexity and biological potential. Its role as a pharmacophore in drug discovery underscores its importance as a building block for novel therapeutics. As research continues to uncover new applications for this compound, it is likely to remain at the forefront of pharmaceutical innovation. The ongoing exploration of its derivatives promises further breakthroughs in treating complex diseases across multiple therapeutic areas.

• 2941-62-0(2-methyl-1,3-benzothiazol-6-amine)
• 13382-43-9(2-methyl-1,3-benzothiazol-5-amine)
• 58460-31-4(6-Benzothiazolamine, 5-chloro-2-(1,1-dimethylethyl)-)
• 34257-30-2(7-Benzothiazolamine,6-chloro-2-methyl-)
• 1006-99-1(5-Chloro-2-methyl-1,3-benzothiazole)
• 32770-99-3(5-Amino-2-methylbenzothiazole dihydrochloride)
• 4146-24-1(6-chloro-2-methyl-1,3-benzothiazole)
• 10023-33-3(2-methyl-1,3-benzothiazol-4-amine)
• 101258-09-7(5,6-Diamino-2-methyl-benzothiazole)
• 58460-38-1(6-Benzothiazolamine, 5-chloro-2-(1-methylethyl)-)